Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Steven Edmundowicz MD, MASGE

Steven A. Edmundowicz MD, MASGE

Professor and Interim Division Director of Gastroenterology and Hepatology, University of Colorado School of Medicine; Medical Director, Digestive Health Center, University of Colorado Hospital, Aurora, Colorado

Biographical Sketch:

Dr. Edmundowicz is a Past President and Master of the American Society for Gastrointestinal Endoscopy. He has served on the ASGE Governing Board as a councilor from 2010-2013; as Treasurer-elect from 2013 to 2014; as Treasurer from 2014 to 2017; and as President-elect from 2017 to 2018 and President 2018-2019. He also served as Trustee of the ASGE Foundation from 2014 to 2018. He is currently a councilor on the Governing Board until May 2021.

Dr. Edmundowicz is a Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Colorado School of Medicine in Aurora, Colorado. He is also the Medical Director of the Digestive Health Center at the University of Colorado Hospital. He received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania, and completed residency training in internal medicine at Washington University School of Medicine in St. Louis, where he also completed his fellowship in gastroenterology. He has held leadership positions in Gastroenterology and Endoscopy at Washington University School of Medicine, Jefferson Medical College, Allegheny University of the Health Sciences, and the University of Colorado.

He remains active in clinical practice, clinical investigation, teaching, and administration. He has participated in numerous clinical trials in endoscopy, ERCP, and endoscopic ultrasound. Most recently, he has been involved with trials of innovative endoscopic devices for use in the management of gastroesophageal reflux disease and morbid obesity. Dr. Edmundowicz’s clinical research focus involves the study and application of new technologies in endoscopy.

In addition to his other responsibilities, he has served as associate editor for ASGE News, and he was past senior associate editor of ASGE’s peer-reviewed journal, Gastrointestinal Endoscopy.

Positions:
Medical Director, Digestive Health Center, University of Colorado Hospital; Professor of Medicine, University of Colorado School of Medicine, Aurora, Colorado

Degrees:
MD: Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

Postgraduate Training:
Fellowship (gastroenterology): Washington University School of Medicine, St. Louis, Missouri

Clinical Interests:
Study and application of new technologies in endoscopy

Disclosures

Steven A. Edmundowicz MD University of Colorado employee number 240032

NPI # 1780601229

Conflict of Interest Document Updated 6/06/2023

To the best of my knowledge, this represents all known potential conflicts of interest that my spouse and I have with all health care goods and service providers over the past 3 years.

Companies and Patents

Co-Founder: Aspero Medical developed through the University of Colorado Office of Technology Transfer 1/3 owner Patent # 101385-614262. This is a start up medical device company with balloon overtube technology for diagnostic examination of the small intestine and therapies in the upper and lower GI tract.

Stock or Stock Options for Steven A. Edmundowicz (SAE)

Motus GI: colon-cleansing device for colonoscopy
Medical advisory board 2013 to present

Stock options 2013 to present, stock converted 2018 to present

Elira : device to stimulate T6 dermatome for obesity
Medical advisory board member, PI for clinical studies

Stockholder 2015 to present

Medical Advisory Boards

Olympus
Medical Advisory Board (EMF) 2012-present

Paid Consultant 2007-present

Paid Consultant Relationships

Elsevier Publications Associate Editor of Gastroenterology Daily Digest website 2014 to present

Allurion Data Safety Monitoring Board Chair, Paid Consultant 2017 to 2021. Site PI 2023 A balloon technology for obesity

Fractyl Data Safety Monitoring Board Committee, Paid Consultant 2019-2020 Clinical Evaluation Committee, Chair 2021- present A duodenal mucosal resurfacing company for treatment of DM and NASH

Medpace Consultant for blinded review of endoscopic video images for clinical studies 1/2020 to present

Provation Medical Advisory Board Member July 2020-present. EMR and other software for endoscopy

Dragonfly Endoscopy LLC. Consultant, medical advisor and stock option holder. 2021- present. Developer of disposable cholangioscopy platforms not yet FDA approved or sold.

Boston Scientific Consultant for educational programs 2021

Magentiq Eye LTD Consultant, medical advisor and equity holder. AI technology for colonoscopy (polyp detection and characterization) Not yet FDA approved. 2021-2022

Research Support (site specific financial or equipment only)

Elira Site Research Support 2018-2019 and 2021-present
AMBU Site Research Support 2020-2021
Boston Scientific Site Research Support 2016-present
Olympus Site Research Support 2021-present

Steris Site Research Support 2021-present

Meals at regional and national society meetings and events for faculty where NPI numbers were recorded and reported to Open Payments by:

Covidien
Medtronic
Wilson Cook
Boston Scientific

Apollo Endosurgery

Spouse (Annemarie Edmundowicz) Stock or Stock Options:

UV Concepts Incorporated stock purchased by Annemarie Edmundowicz
Elira stock options purchased by Annemarie Edmundowicz
Motus GI stock purchased by Annemarie Edmundowicz
Dragonfly LLC stock options purchased by Annemarie Edmundowicz

Son (Brent James Edmundowicz) employee at UV Concepts in Denver

Start-up that produces a UV light disinfection system for durable medical products.